Re:Safeway, Theranos Split After $350M Deal Fizzles
by empressplay on Tuesday November 10, 2015 @09:58PM
(#10544544)
No, the idea of having fast-turnaround blood-tests is the central focus of Theranos, one which it looks more and more likely it's failing to (and will seemingly never) deliver.
[ Parent
| on HN ]
There are no comments on this comment yet.